Taro-zoledronic Acid Injection Drug, Used For Osteoporosis And Page's Disease, Recalled Because It May Contain Particulate Matter
Recall Summary Taro-Zoledronic acid injection 5mg/100mL, a medication used to treat osteoporosis and Paget's disease, has been recalled across Canada because some batches may contain particulate matter (small particles) in the solution. This is a quality issue with the drug product itself. The recall affects all patients in Canada who may have received this medication.
- Product
- Taro-Zoledronic acid injection 5mg/100mL (DIN 02415100)
- Reason
- Product quality
- Category
- consumer product recall
- Country
- Canada
- Agency
- HC-PRODUCTS
- Recall date
- 2022-08-09
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-PRODUCTS
Recall details on Nibble Recalls: https://trynibble.app/recalls/a52facb0-c4c3-4e69-a900-14ff6311aa32